Improving the Enantioselectivity of CHMO Brevi 1 for Asymmetric Synthesis of Podophyllotoxin Precursor
ChemBioChem · 2023
DOI: 10.1002/cbic.202300582 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemBioChem, 2023. Verfasst von Shou-Cheng Huang und 6 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Bioreactor Engineering, Shanghai Collaborative Innovation Center for Biomanufacturing, School of Biotechnology, East China Un…. Hauptthemen laut MEDLINE: Podophyllotoxin, Oxygenases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, Program of Shanghai Academic Research Leader.
Abstract (Originalsprache)
( R )‐β‐piperonyl‐γ‐butyrolactones are key building blocks for the synthesis of podophyllotoxin, which have demonstrated remarkable potential in cancer treatment. Baeyer‐Villiger monooxygenases (BVMOs)‐mediated asymmetric oxidation is a green approach to produce chiral lactones. While several BVMOs were able to oxidize the corresponding cyclobutanone, most BVMOs gave the ( S ) enantiomer while Cyclohexanone monooxygenase (CHMO) from Brevibacterium sp. HCU1 gave ( R ) enantiomer, but with a low enantioselectivity (75 % ee ). In this study, we use a strategy called “focused rational iterative site‐specific mutagenesis” (FRISM) at residues ranging from 6 Å from substrate. The mutations by using a restricted set of rationally chosen amino acids allow the formation of a small mutant library. By generating and screening less than 60 variants, we achieved a high ee of 96.8 %. Coupled with the cofactor regeneration system, 9.3 mM substrate was converted completely in a 100‐mL scale reaction. Therefore, our work reveals a promising synthetic method for ( R )‐β‐piperonyl‐γ‐butyrolactone with the highest enantioselectivity, and provides a new opportunity for the chem‐enzymatic synthesis of podophyllotoxin.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Bioreactor Engineering, Shanghai Collaborative Innovation Center for Biomanufacturing, School of Biotechnology, East China University of Science and Technology, 130 Meilong Road, Shanghai, 200237…
- Key Laboratory for Advanced Materials, Joint International Research Laboratory of Precision Chemistry and Molecular Engineering, School of Chemistry and Molecular Engineering, East China University of Science & Technolo…
ORCID-Profile: Jian-He Xu, Hui-Lei Yu
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Program of China
- Program of Shanghai Academic Research Leader
Zitieren
APA
Huang, S. C., Zhang, Y. K., Geng, Q., Huang, Q. K., Xu, J. H., Chen, Y. F., & Yu, H. L. (2023). Improving the Enantioselectivity of CHMO Brevi 1 for Asymmetric Synthesis of Podophyllotoxin Precursor. ChemBioChem. https://doi.org/10.1002/cbic.202300582
Vancouver
Huang SC, Zhang YK, Geng Q, Huang QK, Xu JH, Chen YF, et al. Improving the Enantioselectivity of CHMO Brevi 1 for Asymmetric Synthesis of Podophyllotoxin Precursor. ChemBioChem. 2023. doi:10.1002/cbic.202300582
BibTeX
@article{Huang2023,
author = {Huang, Shou-Cheng and Zhang, Yi-Ke and Geng, Qiang and Huang, Qi-Kang and Xu, Jian-He and Chen, Yi-Feng and Yu, Hui-Lei},
title = {Improving the Enantioselectivity of CHMO Brevi 1 for Asymmetric Synthesis of Podophyllotoxin Precursor},
journal = {ChemBioChem},
year = {2023},
doi = {10.1002/cbic.202300582}
}
EUVIMED